By a News Reporter-Staff News Editor at Veterinary Week -- Data detailed on Molecular Imaging have been presented. According to news reporting originating in Merelbeke, Belgium, by VerticalNews journalists, research stated, "Veterinarians have gained increasing access to positron emission tomography (PET and PET/CT) imaging facilities, allowing them to use this powerful molecular imaging technique for clinical and research applications. SPECT is currently being used more in Europe than in the United States and has been shown to be useful in veterinary oncology and in the evaluation of orthopedic diseases."
The news reporters obtained a quote from the research from Ghent University, "SPECT brain perfusion and receptor imaging is used to investigate behavioral disorders in animals that have interesting similarities to human psychiatric disorders. This article provides an overview of the potential applications of PET and SPECT. The use of commercially available and investigational PET radiopharmaceuticals in the management of veterinary disease has been discussed. To date, most of the work in this field has utilized the commercially available PET tracer, F-18-fluorodeoxyglucose for oncologic imaging. Normal biodistribution studies in several companion animal species (cats, dogs, and birds) have been published to assist in lesion detection and interpretation for veterinary radiologists and clinicians. Studies evaluating other F-18-labeled tracers for research applications are underway at several institutions and companion animal models of human diseases are being increasingly recognized for their value in biomarker and therapy development. Although PET and SPECT technologies are in their infancy for clinical veterinary medicine, increasing access to and interest in these applications and other molecular imaging techniques has led to a greater knowledge and collective body of expertise for veterinarians worldwide."
According to the news reporters, the research concluded: "Initiation and fostering of physician-veterinarian collaborations are key components to the forward movement of this field."
For more information on this research see: PET and SPECT Imaging in Veterinary Medicine. Seminars in Nuclear Medicine, 2014;44(1):47-56. Seminars in Nuclear Medicine can be contacted at: W B Saunders Co-Elsevier Inc, 1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, USA. (Elsevier - www.elsevier.com; Seminars in Nuclear Medicine - www.elsevier.com/wps/product/cws_home/623184)
Our news correspondents report that additional information may be obtained by contacting A.K. LeBlanc, University of Ghent, Fac Vet Med, Dept. of Med Imaging & Small Anim Orthopaed, Merelbeke, Belgium.
Keywords for this news article include: Europe, Belgium, Merelbeke, Veterinarian, Nanotechnology, Molecular Imaging, Emerging Technologies
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC